Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

2

3 Bellwether Reports to Watch This Week

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Though some companies have already started reporting earnings for the third quarter, things will really be ramping into gear this week, with several big names coming out with their results.

Though there's absolutely no single metric that can give you an accurate measure of where the economy is at, investors sometimes look at certain companies as bellwethers -- indicators for larger macroeconomic trends at play.

This week, I'll be focusing on three such companies, which vary greatly by both industry and size. I'll tell you what to look for, and at the end, I'll offer up a special free report on the other major event on our time horizon: the presidential election.

Below are the three companies I'll be watching, when they report results, and what analysts are expecting.

Company

Earnings Date

Expected EPS

Expected Revenue

Intuitive Surgical (Nasdaq: ISRG  )

Tues. Nov. 16

$3.50

$535 million

Halliburton (NYSE: HAL  )

Weds. Nov. 17

$0.68

$7.1 billion

Philip Morris (NYSE: PM  )

Thurs. Nov. 18

$1.39

$8.2 billion

Source: E*TRADE. 

Intuitive Surgical
By far the smallest of the three companies on this list, Intuitive could be a good proxy for certain companies in the medical devices field. The company's da Vinci Surgical Robot has gained wide enough acceptance that its usefulness is generally accepted in the medical community.

For that reason, a low number of orders may be more representative of tight hospital budgets than dissatisfaction with the company's key product. If this is the case, other medical device companies like Accuray (Nasdaq: ARAY  ) -- which makes the CyberKnife, which helps deliver radiation to tumors -- could face similar troubles.

During the last conference call, the company said there was a significant slowdown in prostatectomies, and that the trend could continue for some time.

Stepping away from the macro view, investors shouldn't get too worried about a slowdown in Europe. The situation will resolve itself -- someday -- and Intuitive Surgical has no control over when that will be. In the meantime, I recently thought the stock's price was tempting enough to add more shares to my own account.

Halliburton
Though it may not be the biggest player in the oil services field, earnings from Halliburton can give investors an idea for where the industry may be headed.

There are two things to keep in mind for this week's earnings:

The company is currently working through an oversupply of guar on its hands -- a substance that is used in the fracking process. That may negatively impact earnings, but is more of a short-term problem.

The bigger piece to keep your eye on will be the possible increase in rig counts worldwide that the company is helping to service. As the globe's appetite for oil grows, and supplies dwindle, companies are willing to spend more and more money to extract the substance -- much to Halliburton's benefit.

Philip Morris International
One important thing to remember with Philip Morris is that it's not the same company many may remember from decades past. Back in 2003, Altria (NYSE: MO  ) split with Philip Morris; the former focuses on cigarette sales stateside, while the latter focuses internationally.

Though they're certainly not "necessity" goods, cigarettes' addictive nature makes them regular purchases by billions of people every day. For that reason, a dip in sales could be indicative of a larger pattern of penny-pinching, while steady output could represent a more stable global outlook.

Of course, there are other factors that could come into play, like possible legislation internationally, or huge swaths of people choosing to give up the habit for health reasons. But since there's been no big news on either of these fronts over the past three months, that's unlikely.

Instead, investors should focus on whether the company can continue its recent revenue growth. Analysts are expecting revenue to increase by 5% between 2012 and 2013 -- though it's actually expected to take a slight dip this quarter from the same time last year. 

Earnings season is just one "big event"
Beyond the usual earnings season chatter, every four years we have another event competing for our attention: the presidential election.  Though no one can tell what a potential candidate might do in office, both Barack Obama and Mitt Romney have signaled what they hope to accomplish in office.

Check out our free report: "These Stocks Could Skyrocket After the 2012 Presidential Election." The candidates have competing visions for getting America back on track, but The Motley Fool will have you prepared to profit -- no matter who wins! Download your copy now, for free, and discover hidden ways to profit from the election.

 

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Fool contributor Brian Stoffel owns shares of Intuitive Surgical. The Motley Fool owns shares of Halliburton Company and Intuitive Surgical. Motley Fool newsletter services recommend Halliburton Company and Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 15, 2012, at 11:49 AM, PauvrePapillon wrote:

    The "significant slowdown" is prostatectomies reported by Inuitive Surgical could also mean that a critical mass of patients has finally figured out that surgery (whether open or daVinci-assisted) entails significantly greater risk of complications such as incontinence and impotence than treatment by non-invasive CyberKnife radiosurgery with no gain whatsoever in long term patient outcome.

    With reimbursement rates set by Medicare encouraging them to do so, urologists have been misleading patients for years into an inferior treatment paradigm with the argument that the data favoring CyberKnife wasn’t seasoned enough to be trusted. Now that we have five-year comparison data, that caveat is no longer merely specious, it’s fraudulent. Maybe the word is finally getting out.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 2057145, ~/Articles/ArticleHandler.aspx, 5/19/2013 6:32:03 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 15,354.40 121.18 0.80%
S&P 500 1,667.47 17.00 1.03%
NASD 3,498.97 33.73 0.97%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/17/2013 4:00 PM
MO $37.44 Up +0.26 +0.70%
Altria Group, Inc. CAPS Rating: *****
PM $95.68 Up +0.24 +0.25%
Philip Morris Inte… CAPS Rating: *****
ISRG $484.00 Up +7.78 +1.63%
Intuitive Surgical CAPS Rating: ****
ARAY $5.26 Up +0.11 +2.14%
Accuray, Inc. CAPS Rating: ****
HAL $45.25 Up +1.40 +3.19%
Halliburton CAPS Rating: *****

Advertisement